COLLEGIUM PHARMACEUTICAL INC (COLL)

US19459J1043 - Common Stock

29.7  -0.74 (-2.43%)

After market: 30 +0.3 (+1.01%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to COLL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 43.1. This target is 45.1% above the current price.
COLL was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about COLL.
In the previous month the buy percentage consensus was at a similar level.
COLL was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 29.7037.3741.8243.1052.50 - 25.82% 40.81% 45.10% 76.77%
Up and Down Grades
Date Firm Action Rating
2024-10-11 Piper Sandler Reiterate Neutral -> Neutral
2024-09-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-09 Needham Reiterate Hold
2024-08-09 Truist Securities Maintains Buy -> Buy
2024-08-09 Piper Sandler Reiterate Neutral -> Neutral
2024-07-30 Needham Reiterate Hold
2024-07-30 HC Wainwright & Co. Upgrade Neutral -> Buy
2024-06-07 Jefferies Upgrade Hold -> Buy
2024-05-10 Needham Downgrade Buy -> Hold
2024-05-10 Piper Sandler Downgrade Overweight -> Neutral
2024-04-11 Needham Reiterate Buy -> Buy
2024-02-26 Truist Securities Maintains Buy -> Buy
2024-02-23 Piper Sandler Reiterate Overweight -> Overweight
2024-02-02 Needham Reiterate Buy -> Buy
2024-01-04 Needham Maintains Buy -> Buy
2024-01-04 Truist Securities Maintains Buy -> Buy
2024-01-04 Jefferies Downgrade Buy -> Hold
2023-08-25 Needham Maintains Buy -> Buy
2023-08-04 Needham Reiterate Buy -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Neutral
2023-05-30 Needham Reiterate Buy -> Buy
2023-05-05 Needham Reiterate Buy
2023-04-19 Needham Reiterate Buy
2023-02-24 Needham Reiterate Buy
2023-02-08 Needham Reiterate Buy
2023-01-05 Needham Maintains Buy
2022-11-04 Needham Maintains Buy
2022-08-08 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-02-22 Piper Sandler Maintains Overweight
2022-02-15 Needham Maintains Buy